@article{article, title  = {{Assessing the value of new antimicrobials: evaluations of cefiderocol and ceftazidime-avibactam to inform delinked payments by the NHS in England}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/220473 }},

 year = {{2024}},

 month = {{11}},

 author = {{Woods B and Kearns B and Schmitt L and Jankovic D and Rothery C and Harnan S and Hamilton J and Scope A and Ren S and Bojke L and Wilcox M et al}},

 doi = {{10.1007/s40258-024-00924-x}},

 volume = {{23}},

 journal = {{Applied Health Economics and Health Policy}},

 issue = {{1}},

 pages = {{5-17}},

 note = {{Accessed on 2025/11/02}}}